Peregrine Pharmaceuticals shares owned by T. Rowe Price Associates
Quarter-by-quarter ownership of Peregrine Pharmaceuticals (CDMO) shares owned by T. Rowe Price Associates
from 13F filings
Historical chart of T. Rowe Price Associates investment in Peregrine Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Peregrine Pharmaceuticals held by T. Rowe Price Associates consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Peregrine Pharmaceuticals by T. Rowe Price Associates
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $380k | 33k | 11.40 |
| 2024-06-30 | $236k | 33k | 7.14 |
| 2024-03-31 | $204k | 30k | 6.73 |
| 2023-12-31 | $187k | 29k | 6.53 |
| 2023-09-30 | $247k | 26k | 9.46 |
| 2023-06-30 | $346k | 25k | 13.98 |
| 2023-03-31 | $448k | 24k | 18.76 |
| 2022-12-31 | $319k | 23k | 13.76 |
| 2022-03-31 | $364k | 18k | 20.35 |
| 2021-12-31 | $480k | 16k | 29.18 |